LeonaBio (LONA) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
LeonaBio insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $99K of LONA stock on the open market.
Get emailed when insiders cluster-buy stocks like LONA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
LONA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $99K | 10 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 LeonaBio, Inc. insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $99K. 0 of 10 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Mar 5SEC | Mark James LittonCEO, President | Sell | 5,15657,926 held (−8%) | $5.37 | $28K | +7.1% | — |
| Mar 5SEC | Martin Javier SanChief Medical Officer | Sell | 1,72015,887 held (−10%) | $5.37 | $9K | +7.1% | — |
| Mar 5SEC | Kevin ChurchChief Scientific Officer | Sell | 1,35925,178 held (−5%) | $5.37 | $7K | +7.1% | — |
| Mar 5SEC | Mark WorthingtonGeneral Counsel | Sell | 1,32818,376 held (−7%) | $5.37 | $7K | +7.1% | — |
| Mar 5SEC | Robert RenningerCFO | Sell | 90615,851 held (−5%) | $5.37 | $5K | +7.1% | — |
| Jan 5SEC | Mark James LittonCEO, President | Sell | 2,58640,828 held (−6%) | $6.88 | $18K | -16.4% | — |
| Jan 5SEC | Martin Javier SanChief Medical Officer | Sell | 1,64410,189 held (−14%) | $6.88 | $11K | -16.4% | — |
| Jan 5SEC | Kevin ChurchChief Scientific Officer | Sell | 87620,681 held (−4%) | $6.88 | $6K | -16.4% | — |
| Jan 5SEC | Mark WorthingtonGeneral Counsel | Sell | 87613,978 held (−6%) | $6.88 | $6K | -16.4% | — |
| Jan 5SEC | Robert RenningerCFO | Sell | 29712,857 held (−2%) | $6.88 | $2K | -16.4% | — |
Insiders at LeonaBio, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Mark James LittonCEO, President | — | $45K | Mar 5, 2026 | — |
| Martin Javier SanChief Medical Officer | — | $21K | Mar 5, 2026 | — |
| Kevin ChurchChief Scientific Officer | — | $13K | Mar 5, 2026 | — |
| Mark WorthingtonGeneral Counsel | — | $13K | Mar 5, 2026 | — |
| Robert RenningerCFO | — | $7K | Mar 5, 2026 | — |
LONA stock: common questions
Are LeonaBio, Inc. insiders buying LONA stock?
In the past 12 months, 0 insiders reported open-market purchases of LONA worth $0.
Are LeonaBio, Inc. insiders selling LONA stock?
5 insiders reported sales worth $99K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is LONA's 52-week range?
Over the past year LONA has traded between $2.87 and $11.68. It last closed at $5.75 on Oct 9, 2026.